ClinicalTrials.gov · 2026

SUPREME-02 (NCT07526974): Phase 3 CBL-514 for abdominal subcutaneous fat

ClinicalTrials.gov (2026). SUPREME-02 (NCT07526974): Phase 3 CBL-514 for abdominal subcutaneous fat. Clinical trial registry.

Clinical trial registry

Source: https://clinicaltrials.gov/study/NCT07526974

Last reviewed . By the PeptIQ team.

Peptides linked in PeptIQ Wiki

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.